Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Cytek Biosciences highlights its expanding role in clinical research through spectral flow cytometry at the 2026 ESCCA and ICCS conferences. The company will demonstrate its Full Spectrum Profiling (FSP) technology, which enhances cell analysis capabilities and workflow efficiency. Presentations and workshops will focus on innovative applications i…
Rogers Communications and Quebecor have agreed on a new 12-year sublicensing deal starting in the 2026-27 season, granting Quebecor's TVA Sports broadcasting rights to up to 350 national NHL games annually in French, including increased coverage of Montréal Canadiens games and playoffs. This deal expands French-language access to NHL games across v…
Teladoc Health announced inducement awards for Michael Grasher upon joining as Chief Financial Officer on September 1, 2026. The awards include restricted stock units and performance stock units tied to adjusted EBITDA and revenue growth targets. Vesting schedules extend through 2029 based on continued service and performance milestones.
DBV Technologies, a late-stage biopharmaceutical company specializing in treatment options for food allergies, announced its participation in major investor conferences in September 2026 including Cantor Global Healthcare, Citi Biopharma Back to School, and H.C. Wainwright Global Investment Conference. The company plans to present updates on its pr…
Tenaya Therapeutics, a clinical-stage biotechnology company focused on developing gene therapies for heart diseases, announced its participation in the upcoming H.C. Wainwright and Morgan Stanley healthcare investor conferences in September 2026. Management will engage with investors through meetings and a fireside chat to discuss their pipeline in…
Globus Medical announced that its Excelsius3D intelligent 3-in-1 imaging system has received CE Mark approval for commercial sale within the European Union and the United Kingdom. This marks a significant expansion of the company's Excelsius Ecosystem, enhancing surgical workflows by integrating advanced intraoperative imaging with robotic navigati…
Weatherford International plc announced shareholder approval to redomesticate from Ireland to Delaware, aiming to streamline its corporate structure, align better with global operations, and achieve $20–30 million in annual cash savings starting in 2027. The move is expected to enhance financial flexibility and support long-term value creation, sub…
Root, Inc., a leading technology company in car insurance, announced its participation in the upcoming KBW Insurance Conference and Goldman Sachs Americas Financial Technology Conference. The company will engage in one-on-one and group meetings with institutional investors but will not hold a general presentation. Investor materials are available o…
FingerMotion, Inc. entered a non-binding memorandum of understanding with Lyken AI Computing and BlueFlare Energy to create a demand-to-capacity matching framework for AI and HPC enterprise workloads in Western Canada, focusing on Alberta corridor sites. The company also provided updates on ongoing natural gas supply discussions supporting behind-t…
Dentsply Sirona Inc., a leading global manufacturer of dental products and technologies, announced its participation in the Baird 2026 Global Healthcare Conference with a scheduled management presentation. The event offers an opportunity to showcase its innovations and connect with investors via a live webcast.
Quanex Building Products Corporation announced its financial results for Q3 2026, reporting net sales growth to $501.8 million, margin improvements particularly in the Hardware Solutions segment, and repayment of $42.25 million in debt. Adjusted EBITDA increased to $72.7 million, highlighting operational progress despite macroeconomic inflation pre…
Palomar Holdings, Inc., a specialty insurer, announced that its President and CFO will present at the KBW Insurance Conference, providing investors with an update on company performance and strategy, with a live webcast available on their investor relations website.
Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision products and solutions in China, has successfully completed a best-efforts follow-on public offering, raising approximately $11 million. The offering included units composed of Class A Ordinary Shares and warrants. Proceeds from the offering will be used p…
Vivani Medical, a clinical-stage biopharmaceutical company developing innovative drug implants using its proprietary NanoPortal™ platform, announced its participation in the Lake Street Capital Markets Best Ideas Growth Conference and the H.C. Wainwright Annual Global Investment Conference in September 2026. The company focuses on long-acting GLP-1…
U.S. Global Investors, Inc. (NASDAQ: GROW) announced a net income of $3.1 million for fiscal year 2026, reversing a net loss of $334,000 the prior year. Operating revenue increased 21% to $10.3 million, supported by higher advisory fees from gold and natural resources funds and increased assets under management. The company’s Technology and Aerospa…
Attovia Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation biotherapeutics for immune-mediated diseases, announced management participation in upcoming investor conferences hosted by Citi and Morgan Stanley. The company highlighted its clinical and IND-enabling programs targeting multiple inflammatory and…
LB Pharmaceuticals, a neuromedicines company focused on therapies for brain disorders, announced its executive team will participate in several upcoming investor conferences in September 2026, including Wells Fargo Healthcare Conference, H.C. Wainwright Global Investment Conference, and TD Cowen Neuropsychiatry Summit. Presentations will be availab…
Zscaler, Inc. announced strong fiscal Q4 and 2026 financial results with 25% year-over-year growth in revenue and annual recurring revenue (ARR). The company highlighted expanded platform adoption driven by innovations in AI security, Zero Trust SASE, and SecOps. Non-GAAP operating margin reached a record 24%, and guidance for fiscal 2027 projects …
CapsoVision, Inc., a NASDAQ-listed medical technology company specializing in AI-enabled capsule endoscopy solutions, announced that its executive team will participate in the H.C. Wainwright Global Investment Conference and the ROTH Healthcare Opportunities Conference. The presentations aim to highlight its advanced imaging products for gastrointe…
Reliance Global Group, Inc. (Nasdaq: EZRA) announced the adoption of a one-year stockholder rights plan designed to protect stockholder value by preventing coercive or undervalued takeover attempts. The plan allows the Board time to evaluate unsolicited offers and explore alternatives to maximize shareholder returns, while not obstructing approved …
Vaxcyte, Inc., a clinical-stage vaccine company, announced the appointment of Luis Jodar, Ph.D., as Chief Medical Officer, and David McAvoy, J.D., as Chief Legal Officer, enhancing its leadership ahead of the expected topline safety, tolerability, and immunogenicity data from its VAX-31 Phase 3 OPUS-1 trial targeting invasive pneumococcal disease. …
Immuneering Corporation, a clinical-stage oncology company focused on developing novel cancer therapies, announced management's participation in two upcoming investor conferences in New York City in September 2026. The events include fireside chats and one-on-one investor meetings, which will be webcast and archived on the company's website. Immune…
Ambarella, a US edge AI semiconductor company, announced a long-term strategic distribution agreement with Macnica to enhance the distribution, technical support, and ecosystem development of Ambarella's edge AI semiconductor products and platforms. This partnership aims to accelerate edge AI and Physical AI adoption by combining Ambarella's silico…
Alector, Inc., a biotechnology company focused on therapies for neurodegenerative diseases, announced management participation in two upcoming investor healthcare conferences in New York. The presentations will include fireside chats and will be webcast live, highlighting Alector's pipeline and technology such as its proprietary blood-brain barrier…
Lifecore Biomedical, a Nasdaq-listed contract development and manufacturing organization specializing in sterile injectable pharmaceuticals, will participate in the CPHI Global Conference in Milan from October 6-8, 2026. Company leaders will meet prospective customers to discuss process development and manufacturing services for injectable programs…
